2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 213 funds opening new positions, 1,177 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,177 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.1%65.94% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,865
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2451
$247K
2452
$247K
2453
$247K
2454
$246K
2455
$246K
2456
$246K
2457
$246K
2458
$245K
2459
$245K
2460
$245K
2461
$245K
2462
$245K
2463
$245K
2464
$244K
2465
$244K
2466
$243K
2467
$243K
2468
$242K
2469
$241K
2470
$241K
2471
$240K
2472
$239K
2473
$239K
2474
$239K
2475
$238K